FindTrial
Sign In

Use of (1,3)-ß-D-glucan kit to detect blood fungal infections early in premature babies

Role of (1,3)-ß-D-glucan in early diagnosis of invasive fungal infections in preterm neonates admitted in neonatal intensive care unit - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/09/073598
Enrollment
553
Registered
2024-09-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P399- Infection specific to the perinatal period, unspecified

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Uttar Pradesh University of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Ptreterm neonates having suspected fungal sepsis

Exclusion criteria

Exclusion criteria: Preterm neonates already on antibiotics before admission

Design outcomes

Primary

MeasureTime frame
Diagnostic efficacy of (1,3)-ß-D-glucan will be compared with blood culture for the diagnosis of invasive fungal infections in preterm neonates.Timepoint: Any time when fungal infections will be suspected during hospitalization—

Secondary

MeasureTime frame
Diagnostic efficacy of one three Beta D Glucan in preterm neonateTimepoint: during fungal infections—

Countries

India

Contacts

Public ContactDURGESH KUMAR

Uttar Pradesh University of Medical Sciences, Saifai, Etawah

drdurgeshk@gmail.com09917144512

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026